Landos Biopharma Inc (LABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LABP | RGC | ANEB | ||
| Company | Landos Biopharma Inc | Regencell Bioscience Holdings Ltd | Anebulo Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 22.35 | 5.00 | 2.70 | ||
| High | 22.55 | 5.35 | 2.70 | ||
| Low | 22.31 | 5.00 | 2.70 | ||
| Last | 22.31 | 5.35 | 2.70 | ||
| Change | -0.18 | +0.25 | -0.09 | ||
| % Change | -0.80% | +4.90% | -3.25% | ||
| Volume | 14,800 | 1,100 | 300 | ||
| 20-Day Average Volume | 20,130 | 8,140 | 5,050 | ||
| Previous Close | 22.49 | 5.10 | 2.79 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 21.74 | 4.38 | 2.83 | ||
| 20-Day Raw Stochastic | 62.41% | 40.26% | 14.80% | ||
| 20-Day Relative Strength | 91.24% | 49.76% | 48.81% | ||
| Weighted Alpha | +246.26 | -82.88 | -12.50 | ||
| Today's Opinion | 100% Buy | 72% Sell | 56% Buy | ||
| Previous Opinion | 100% Buy | 72% Sell | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.25% since 04/19/24 | +2.49% since 04/18/24 | -2.75% since 04/19/24 | ||
| Low | 21.61 on 04/22/24 | 5.00 on 04/25/24 | 2.61 on 04/24/24 | ||
| High | 22.84 on 04/25/24 | 8.60 on 04/23/24 | 2.79 on 04/25/24 | ||
| 1-Month | |||||
| %Chg | +3.48% since 03/26/24 | +44.59% since 03/25/24 | +3.98% since 03/26/24 | ||
| Low | 21.35 on 03/28/24 | 3.16 on 03/26/24 | 2.60 on 04/10/24 | ||
| High | 22.84 on 04/25/24 | 8.60 on 04/23/24 | 3.30 on 04/18/24 | ||
| 3-Month | |||||
| %Chg | +383.95% since 01/26/24 | -34.76% since 01/25/24 | +11.49% since 01/26/24 | ||
| Low | 4.60 on 02/02/24 | 3.16 on 03/26/24 | 2.40 on 03/22/24 | ||
| High | 22.84 on 04/25/24 | 9.50 on 01/30/24 | 3.30 on 04/18/24 | ||
| 6-Month | |||||
| %Chg | +502.97% since 10/26/23 | -68.53% since 10/25/23 | +20.16% since 10/26/23 | ||
| Low | 3.21 on 12/22/23 | 3.16 on 03/26/24 | 1.87 on 12/14/23 | ||
| High | 22.84 on 04/25/24 | 16.99 on 10/27/23 | 3.30 on 04/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 69,589 | 69,620 | 69,301 | ||
| Shares Outstanding, K | 3,119 | 13,013 | 25,633 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -21,940,000 | -5,870,000 | -11,730,000 | ||
| Last Quarter Sales | 0 | N/A | 0 | ||
| Last Quarter Net Income | -6,120,000 | N/A | -2,720,000 | ||
| 60-Month Beta | 0.14 | -0.34 | -1.00 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 03/21/24 | N/A | -0.11 on 02/13/24 | ||
| Latest Earnings Date | 05/10/24 | 01/26/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 02/15/18 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||